134 related articles for article (PubMed ID: 24970925)
1. Tanshinone II A sulfonate, but not tanshinone II A, acts as potent negative allosteric modulator of the human purinergic receptor P2X7.
Kaiser M; Sobottka H; Fischer W; Schaefer M; Nörenberg W
J Pharmacol Exp Ther; 2014 Sep; 350(3):531-42. PubMed ID: 24970925
[TBL] [Abstract][Full Text] [Related]
2. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
[TBL] [Abstract][Full Text] [Related]
3. Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors.
Nörenberg W; Sobottka H; Hempel C; Plötz T; Fischer W; Schmalzing G; Schaefer M
Br J Pharmacol; 2012 Sep; 167(1):48-66. PubMed ID: 22506590
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P
Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
[TBL] [Abstract][Full Text] [Related]
5. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H
J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel purine-based heterocyclic P2X7 receptor antagonists.
Kwak SH; Lee WG; Lee YJ; Lee SD; Kim YC; Ko H
Bioorg Chem; 2015 Aug; 61():58-65. PubMed ID: 26123174
[TBL] [Abstract][Full Text] [Related]
7. Natural compounds with P2X7 receptor-modulating properties.
Fischer W; Urban N; Immig K; Franke H; Schaefer M
Purinergic Signal; 2014; 10(2):313-26. PubMed ID: 24163006
[TBL] [Abstract][Full Text] [Related]
8. Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action.
Marques-da-Silva C; Chaves MM; Castro NG; Coutinho-Silva R; Guimaraes MZ
Br J Pharmacol; 2011 Jul; 163(5):912-26. PubMed ID: 21306580
[TBL] [Abstract][Full Text] [Related]
9. 6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist.
Cuthbertson P; Elhage A; Al-Rifai D; Sophocleous RA; Turner RJ; Aboelela A; Majed H; Bujaroski RS; Jalilian I; Kelso MJ; Watson D; Buckley BJ; Sluyter R
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139148
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of the rhesus macaque monkey P2X7 receptor.
Bradley HJ; Browne LE; Yang W; Jiang LH
Br J Pharmacol; 2011 Sep; 164(2b):743-54. PubMed ID: 21457228
[TBL] [Abstract][Full Text] [Related]
11. P2X4 receptor regulates P2X7 receptor-dependent IL-1β and IL-18 release in mouse bone marrow-derived dendritic cells.
Sakaki H; Fujiwaki T; Tsukimoto M; Kawano A; Harada H; Kojima S
Biochem Biophys Res Commun; 2013 Mar; 432(3):406-11. PubMed ID: 23428419
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
Park JH; Lee GE; Lee SD; Ko H; Kim YC
Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release.
Barberà-Cremades M; Baroja-Mazo A; Gomez AI; Machado F; Di Virgilio F; Pelegrín P
FASEB J; 2012 Jul; 26(7):2951-62. PubMed ID: 22490780
[TBL] [Abstract][Full Text] [Related]
14. ATP-induced currents carried through P2X7 receptor in rat myometrial cells.
Miyoshi H; Yamaoka K; Urabe S; Kudo Y
Reprod Sci; 2012 Dec; 19(12):1285-91. PubMed ID: 22814097
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexamethasone on purinergic signaling in murine mast cells: Selective suppression of P2X7 receptor expression.
Yoshida K; Ito M; Hoshino Y; Matsuoka I
Biochem Biophys Res Commun; 2017 Dec; 493(4):1587-1593. PubMed ID: 28988113
[TBL] [Abstract][Full Text] [Related]
16. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation.
Calzaferri F; Narros-Fernández P; de Pascual R; de Diego AMG; Nicke A; Egea J; García AG; de Los Ríos C
J Med Chem; 2021 Feb; 64(4):2272-2290. PubMed ID: 33560845
[TBL] [Abstract][Full Text] [Related]
18. Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations.
Nörenberg W; Hempel C; Urban N; Sobottka H; Illes P; Schaefer M
J Biol Chem; 2011 Apr; 286(13):11067-81. PubMed ID: 21262970
[TBL] [Abstract][Full Text] [Related]
19. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
20. Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation.
Danquah W; Meyer-Schwesinger C; Rissiek B; Pinto C; Serracant-Prat A; Amadi M; Iacenda D; Knop JH; Hammel A; Bergmann P; Schwarz N; Assunção J; Rotthier W; Haag F; Tolosa E; Bannas P; Boué-Grabot E; Magnus T; Laeremans T; Stortelers C; Koch-Nolte F
Sci Transl Med; 2016 Nov; 8(366):366ra162. PubMed ID: 27881823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
